✦ LIBER ✦

62 PHASE II HCVac STUDY OF TG4040 IMMUNOTHERAPEUTIC IN COMBINATION WITH PEGIFNa2a AND RIBAVIRIN IN GENOTYPE 1 CHC TREATMENT NAÏVE PATIENTS: SVR24 FINAL RESULTS

✍ Scribed by Wedemeyer, H.; Janczewska Kazek, E.; Wlodzimierz, M.; Stanciu, C.; Habersetzer, F.; Carreno, V.; Di Bisceglie, A.; Tanasescu, C.; Flisiak, R.; Romero-Gomez, M.; Fich, A.; Hennequi, M.; Bain, C.; Zerr, P.; Agathon, D.; Adda, N.; Bonnefoy, J.-Y.; Inchauspé, G.; Ancian, P.; Limacher, J.-M.

Book ID: 122270218
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 62 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60064-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA

1420 ASUNAPREVIR WITH PEGINTERFERON-ALFA AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE-1 OR -4 CHRONIC HEPATITIS C: SVR24 RESULTS FROM A RANDOMIZED PHASE 2B STUDY (AI447016)

✍ Bronowicki, J.-P.; Ratziu, V.; Gadano, A.; Thuluvath, P.J.; Bessone, F.; Martore 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FRO

4 HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT- NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C

✍ P. Kwo; E. Lawitz; J. McCone; E. Schiff; J. Vierling; D. Pound; M. Davis; J. Gal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

OC-13 ADVANCE study: Final results of th

OC-13 ADVANCE study: Final results of the phase III trial with telaprevir in combination with PEG-IFN and RBV in treatment-naïve genotype 1 HCV

✍ M. Rizzetto; P. Andreone; M. Colombo; A. Scuteri; A. Ciancio; A. Smedile; N. Add 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

57 ACTIVITY OF TELAPREVIR ALONE OR IN CO

57 ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209

✍ G.R. Foster; C. Hezode; J.-P. Bronowicki; G. Carosi; O. Weiland; L. Verlinden; R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB

15 TELAPREVIR (TVR) q8h OR q12h COMBINED

15 TELAPREVIR (TVR) q8h OR q12h COMBINED WITH EITHER PEGINTERFERON (PEG-IFN, P) ALFA-2A OR ALFA-2B AND RIBAVIRIN (RBV, R) IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C: FINAL RESULTS OF THE RANDOMIZED, OPEN-LABEL, MULTICENTER PHASE 2 STUDY C208

✍ M. Colombo; M.G. Rumi; G. Carosi; M. Puoti; P. Marcellin; X. Forns; T. Göser; P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P1233 EFFICACY AND SAFETY OF MK-5172 PLU

P1233 EFFICACY AND SAFETY OF MK-5172 PLUS RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: FINAL RESULTS OF THE C-SPIRIT STUDY

✍ Gane, E.; Ben Ari, Z.; Mollison, L.; Zuckerman, E.; Bruck, R.; Baruch, Y.; Wahl, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB